Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

11.10 USD -0.05 (-0.45%)
Streaming Delayed Price Updated: 7:25 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biocryst Pharma Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
Research Reports Coverage on Biotech Stocks -- Puma Biotechnology, Dipexium Pharma, BioCryst Pharma, and CTI BioPharma
From PR Newswire
BioCryst to Announce Fourth Quarter and Year End 2016 Financial Results February 27
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that its fourth quarter and full year 2016 financial results will be released on Monday, February 27, 2017. BioCryst will host a conference... 
From GlobeNewswire News Releases
BioCryst Announces the Acceptance of Peramivir MAA Filing by the European Medicines Agency
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, announced today that the European Medicines... 
From GlobeNewswire News Releases
BioCryst Receives Health Canada Approval for RAPIVAB® for the Treatment of Influenza
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today announced that Health Canada has approved... 
From GlobeNewswire News Releases
Research Reports Initiation on Biotech Stocks -- Puma Biotechnology, Seattle Genetics, Advaxis, and BioCryst Pharma
From PR Newswire
BioCryst to Present at the J.P. Morgan Healthcare Conference
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s development... 
From GlobeNewswire News Releases
BioCryst to Present at the Piper Jaffray Healthcare Conference November 30
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate update regarding the Company’s clinical programs at the 28th Annual Piper... 
From GlobeNewswire News Releases
Biotech Stocks on Investors' Radar -- Inovio Pharma, Pacific Biosciences of California, BioCryst Pharma, and Sangamo Biosciences
From PR Newswire
BioCryst Reports Third Quarter 2016 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter ended September 30, 2016. 
From GlobeNewswire News Releases
BioCryst Announces Late Breaker Presentation of Galidesivir (BCX4430) Nonclinical Results in Zika Virus Infection at IDWeek 2016
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that results from a study of galidesivir (formerly BCX4430) administered to Rhesus monkeys infected with Zika virus (ZIKV) will be presented... 
From GlobeNewswire News Releases
BioCryst to Announce Third Quarter 2016 Financial Results November 7
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its third quarter 2016 financial results will be released on Monday, November 7, 2016. BioCryst will host a conference call and webcast... 
From GlobeNewswire News Releases
Biotech Stocks on Investors' Radar -- Alexion Pharma, PDL BioPharma, BioCryst Pharma, and Cara Therapeutics
From PR Newswire
BioCryst Closes $23 Million Senior Credit Facility
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the Company has closed a $23 million Senior Credit Facility with Midcap Financial. The facility was fully funded at closing and bears a... 
From GlobeNewswire News Releases
BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced positive results from a proof-of-concept study of its broad spectrum antiviral, BCX4430, for the delayed treatment of Ebola virus infection... 
From GlobeNewswire News Releases
BioCryst to Present at the Baird 2016 Global Healthcare Conference September 8
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate update regarding the Company’s clinical programs at Baird’s 2016 Global... 
From GlobeNewswire News Releases
Research Reports Initiation on Biotech Stocks -- Hemispherx Biopharma, Vascular Biogenics, BioCryst Pharma, and Alnylam Pharma
From PR Newswire
BioCryst Announces Initiation of the APeX-1 Clinical Trial of BCX7353 for Hereditary Angioedema
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that it has dosed the first subject in the APeX-1 clinical trial of BCX7353 for the oral treatment of hereditary angioedema (HAE). 
From GlobeNewswire News Releases
BioCryst Reports Second Quarter 2016 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter ended June 30, 2016. 
From GlobeNewswire News Releases
BioCryst to Announce Second Quarter 2016 Financial Results August 4
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its second quarter 2016 financial results will be released on Thursday, August 4, 2016. BioCryst will host a conference call and... 
From GlobeNewswire News Releases
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has provided additional funding for efficacy studies of BCX4430 in... 
From GlobeNewswire News Releases
Technical Coverage of Biotechnology Stocks - Agenus, BioCryst Pharma, Cempra, and Hemispherx Biopharma
From PR Newswire
BioCryst to Present at Two Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate update regarding the Company’s clinical programs at the following... 
From GlobeNewswire News Releases
BioCryst Reports First Quarter 2016 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the first quarter ended March 31, 2016. 
From GlobeNewswire News Releases
BioCryst to Announce First Quarter 2016 Financial Results May 5
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its first quarter 2016 financial results will be released on Thursday, May 5, 2016. BioCryst will host a conference call and webcast at... 
From GlobeNewswire News Releases
BioCryst to Present at Two Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate update regarding the Company’s clinical programs at the following... 
From GlobeNewswire News Releases
The Biotech Bull Market Is Back
Tags Banking & Financial Services
From ACCESSWIRE
BioCryst to Present at Barclays Healthcare Conference
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s development... 
From GlobeNewswire News Releases
Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that results from a preclinical study of its broad spectrum antiviral BCX4430 in immune-deficient mice infected with Zika virus will be... 
From GlobeNewswire News Releases
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shareholder Alert: Investigation Announced
San Diego, CA -- (SBWIRE) -- 03/01/2016 -- An investigation for shareholders in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was announced concerning possible breaches of fiduciary duties by certain... 
From SBWire - Latest Press Releases
Healthcare Stocks to Remedy any Portfolio – BCRX, ANAC, ALDR, and FGEN
Tags Publishing & Media
From ACCESSWIRE
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account